Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy.
Int J Infect Dis
; 96: 500-502, 2020 Jul.
Article
em En
| MEDLINE
| ID: mdl-32470602
ABSTRACT
No effective treatment for COVID-19 has been well established yet. Nafamostat, known as anticoagulant, has potential anti-inflammatory and anti-viral activities against COVID-19. We report three cases of COVID-19 pneumonia who progressed while using antiviral drugs and needed supplementary oxygen therapy, improved after treatment with nafamostat. These preliminary findings show the possibility that Nafamostat can be considered to be used in elderly patients with COVID-19 pneumonia who need oxygen therapy. The effectiveness of nafamostat should be evaluated in further studies.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Oxigênio
/
Pneumonia Viral
/
Infecções por Coronavirus
/
Betacoronavirus
/
Guanidinas
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article